American Journal of Infectious Diseases and Microbiology
ISSN (Print): 2328-4056 ISSN (Online): 2328-4064 Website: http://www.sciepub.com/journal/ajidm Editor-in-chief: Maysaa El Sayed Zaki
Open Access
Journal Browser
Go
American Journal of Infectious Diseases and Microbiology. 2016, 4(5), 107-111
DOI: 10.12691/ajidm-4-5-3
Open AccessArticle

Rising Endogenous Interferon–α and Declining Transaminases during Pregnancy in Egyptian Women with Chronic Hepatitis C

Ashraf k.Nassar1, Ebada M. Said1, Elwy M. Soliman2, , Ahmad W. Anwar3, Neveen A. Soliman4, Amaal I. Aly5 and Kandil A. Foad6

1Department of Hepatology, Gastroenterology and Infectious Diseases, Benha University

2Departement of Internal Medicine, Minia University

3Department of Obstetrics & Gynaecology, Faculty of Medicine, Benha University

4Department of Clinical & Chemical Pathology, Faculty of Medicine, Benha University

5Department of Medical Biochemistry, Faculty of Medicine, Benha University

6Department of pediatrics, Benha fever hospital

Pub. Date: November 26, 2016

Cite this paper:
Ashraf k.Nassar, Ebada M. Said, Elwy M. Soliman, Ahmad W. Anwar, Neveen A. Soliman, Amaal I. Aly and Kandil A. Foad. Rising Endogenous Interferon–α and Declining Transaminases during Pregnancy in Egyptian Women with Chronic Hepatitis C. American Journal of Infectious Diseases and Microbiology. 2016; 4(5):107-111. doi: 10.12691/ajidm-4-5-3

Abstract

Background and Study Aims: Immunological changes occurring during pregnancy in HCV-infected women that might protect the foetus attract the attention. Aim was to monitor changes in serum levels of endogenous interferon-α (IFN-α) and transaminases (AST &ALT) in Egyptian pregnant women with chronic hepatitis C (CHC). Patients and Methods: A total of 56 women were studied. Cases group comprised 26 pregnant women with CHC (positive for both anti HCV and HCV- RNA- PCR). Transaminases were assessed in the 3 trimesters while endogenous INF-α was assessed in early 2nd & late 3rd ones. Three control groups were taken 10 women each: pregnant women with negative HCV-Ab, Non pregnant, HCV positive women and Non pregnant, HCV negative groups. Infants born to CHC patients were tested for HCV-RNA-PCR after ≥ 12 months old. Results: Transaminases were statistically significant decreasing as pregnancy was progressing in the cases group. Moreover, in the 3rd trimester, cases group had serum transaminases levels comparable to those of healthy pregnant and non-pregnant-women groups without HCV and significantly lower than those of HCV positive non pregnant women. There was a non-significant rise in viral load in early 2nd and late 3rd trimesters in cases group. Serum endogenous INF-α level was significantly increased when measured in late 3rd compared to that in early 2nd trimester. This rise in serum endogenous INF-α level in the 3rd trimester was significant when compared to all control groups. Fortunately, all the examined 26 infants born to CHC mothers had undetectable HCV-RNA-PCR when were older than 24 months. Conclusion: Endogenous INF- α progressively rises during pregnancy in CHC patients and this might explain the low rates of vertical transmission and the noticeable reduction in transaminases levels in such patients.

Keywords:
endogenous INF chronic hepatitis C pregnancy vertical transmission

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Democratic Republic of Egypt 2008: results from the Demographic and Health Survey. Stud Fam Plann. 41(2): p. 153-8.
 
[2]  Miller, F.D. and L.J. Abu-Raddad, Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A, 2010. 107(33): p. 14757-62.
 
[3]  Conte, D., et al., Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology, 2000. 31(3): p. 751-5.
 
[4]  Costa, Z.B., et al., Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis, 2009. 9: p. 116.
 
[5]  AbdulQawi, K., et al., Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants. Croat Med J, 2010. 51(3): p. 219-28.
 
[6]  Khamis, H.H., et al., Prevalence of hepatitis C virus infection among pregnant women in a rural district in Egypt. Trop Doct, 2016. 46(1): p. 21-7.
 
[7]  Arshad, M., S.S. El-Kamary, and R. Jhaveri, Hepatitis C virus infection during pregnancy and the newborn period--are they opportunities for treatment? J Viral Hepat, 2011. 18(4): p. 229-36.
 
[8]  Hurtado, C.W., et al., Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads. PLoS One, 2010. 5(8): p. e12232.
 
[9]  Aboagye-Mathiesen, G., et al., Functional characteristics of human trophoblast interferons. Am J Reprod Immunol, 1996. 35(4): p. 309-17.
 
[10]  Gibb, D.M., et al., Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet, 2000. 356(9233): p. 904-7.
 
[11]  Hayashida, A., et al., Re-evaluation of the true rate of hepatitis C virus mother-to-child transmission and its novel risk factors based on our two prospective studies. J Obstet Gynaecol Res, 2007. 33(4): p. 417-22.
 
[12]  Floreani, A., Hepatitis C and pregnancy. World J Gastroenterol, 2013. 19(40): p. 6714-20.
 
[13]  Munoz-Gamez, J.A., J. Salmeron, and A. Ruiz-Extremera, [Hepatitis C during pregnancy, vertical transmission and new treatment possibilities]. Med Clin (Barc), 2016.
 
[14]  Floreani, A., et al., Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol, 1996. 103(4): p. 325-9.
 
[15]  van Zonneveld, M., et al., Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat, 2003. 10(4): p. 294-7.
 
[16]  Xiao, X.M., et al., Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet, 2007. 96(3): p. 167-70.
 
[17]  Delamare, C., et al., Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study. J Hepatol, 1999. 31(3): p. 416-20.
 
[18]  Gerotto, M., et al., Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C. Infection, 2006. 34(2): p. 62-5.
 
[19]  McMenamin, M.B., et al., Obstetric management of hepatitis C-positive mothers: analysis of vertical transmission in 559 mother-infant pairs. Am J Obstet Gynecol, 2008. 199(3): p. 315 e1-5.
 
[20]  Shebl, F.M., et al., Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol, 2009. 81(6): p. 1024-31.
 
[21]  Azzari, C., et al., Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. J Med Virol, 2008. 80(1): p. 65-71.
 
[22]  Bevilacqua, E., et al., Genetic factors in mother-to-child transmission of HCV infection. Virology, 2009. 390(1): p. 64-70.
 
[23]  Dowd, K.A., et al., Maternal neutralizing antibody and transmission of hepatitis C virus to infants. J Infect Dis, 2008. 198(11): p. 1651-5.
 
[24]  Paternoster, D.M., et al., Endogenous interferon-alpha level is increased in hepatitis C virus (HCV)-positive pregnant women. J Clin Gastroenterol, 2008. 42(2): p. 204-7.
 
[25]  Gervais, A., et al., Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol, 2000. 32(2): p. 293-9.
 
[26]  Veronesi, L., et al., Mother to child transmission of hepatitis C virus in a province of northern Italy. J Prev Med Hyg, 2007. 48(2): p. 47-9.
 
[27]  Yeung, L.T., et al., Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat, 2007. 14(11): p. 797-805.
 
[28]  Paternoster, D.M., et al., Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol, 2001. 96(9): p. 2751-4.
 
[29]  Roberts, E.A. and L. Yeung, Maternal-infant transmission of hepatitis C virus infection. Hepatology, 2002. 36(5 Suppl 1): p. S106-13.
 
[30]  Floreani, A., Viral Hepatitis and Pregnancy. Current Women’s Health Reviews, 2009. 5(1): p. 8-13.
 
[31]  Kimura, M., et al., Synchronous expansion of intermediate TCR cells in the liver and uterus during pregnancy. Cell Immunol, 1995. 162(1): p. 16-25.
 
[32]  Lin, H.H. and J.H. Kao, Hepatitis C virus load during pregnancy and puerperium. BJOG, 2000. 107(12): p. 1503-6.
 
[33]  Zein, C.O., H. Abu-Lebdeh, and N.N. Zein, Spontaneous clearance of chronic hepatitis C during pregnancy. Am J Gastroenterol, 2001. 96(10): p. 3044-5.
 
[34]  Romero-Gomez, M., et al., [Influence of pregnancy in chronic hepatitis C virus infection]. Med Clin (Barc), 1998. 111(17): p. 641-4.
 
[35]  Ebbesen, P., et al., Concurrence of high levels of interferons alpha and beta in cord and maternal blood and simultaneous presence of interferon in trophoblast in an African population. J Interferon Cytokine Res, 1995. 15(2): p. 123-8.